View in browser

All academics, students, and staff at UC San Diego and UC San Diego Health are invited to honor Juneteenth, a pivotal event in U.S. history. Learn how UC San Diego is observing, reflecting on, and educating about Juneteenth at the link below.

We're excited to share the latest edition of the Cancer Letter, featuring the news of our new associate director appointments. Congratulations to Murphy, McKay, Nodora, Ballantyne, and Stupack on their new roles!

The AACR Cancer Disparities Progress Report 2024 is now available. This report highlights the progress in understanding and addressing cancer disparities, with a significant contribution from Jesse Nodora, MCC Associate Director of Community Outreach & Engagement, on the Steering Committee.

Moores Cancer Center Leadership recently toured the McGrath Outpatient Pavilion, which will launch in July 2025. The McGrath Outpatient Pavilion will offer many outpatient services, including a multi-specialty clinic, infusion, radiation oncology, an endoscopy suite, a retail pharmacy, a Comprehensive Cancer Center, and the Barbara Parker, MD, Breast Center.

The Cure Prize, Curebound's highest award for bold innovation in cancer research, is a $1 million grant to improve the standard of care for a typically deadly cancer with patient application within 3-5 years. The first Cure Prize was awarded to Drs. Penner, McHale, and Dale from UC San Diego last June.

Curebound awarded the second Cure Prize to team representatives Shweta Joshi, PhD, and Andrew Lowy, MD, who focus on improving the standard of care in pancreatic cancer patients. The third Cure Prize was granted to Isabel Newton, MD, PhD, and Adam Burgoyne, MD, PhD, who are working on a minimally invasive treatment to activate the immune system in treating liver cancer.

June 18, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Goldberg Auditorium

July 10, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Comer Commons and Zoom

July 11, 2024 | 4:00 p.m. to 5:00 p.m.

Goldberg Auditorium and Zoom

July 12, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Comer Commons and Zoom

July 17, 2024 | 12:00 p.m. to 1:00 p.m.

Moores Comer Commons and Zoom

The GloCal Health Fellowship is a 12-month, mentored research fellowship that provides aspiring global health researchers with outstanding interdisciplinary education and training in innovative research designed to improve health for populations around the world. Sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC) and the UC Global Health Institute, the GloCal Health Fellowship supports fellows from all 10 UC campuses and 22 affiliated sites across 18 countries.The fellowship is designed for not only U.S. doctoral and professional students and postdoctoral fellows, but also international postdoctoral fellows from affiliated sites in low- and middle-income countries.

For questions, please contact GloCal Health Fellowship Deputy Director, Kimberly Bale, at kimberly.bale@ucsf.edu.

Idea Award

Impact Award

Career Development Award – Scholar Option

Patient Well-Being and Survivorship Award

Through this notice of funding opportunity (NOFO) as a request for applications (RFA), the NCI intends to support multi-level intervention studies that address individual and system-level barriers to transition from pediatric to adult care for survivors of childhood and adolescent cancers. The goal of this opportunity is to support the development and testing of interventions and strategies that promote high-quality transitional care and continued engagement of survivors of childhood and adolescent cancers to ensure these survivors receive appropriate surveillance and care into adulthood. 

Next Deadline - Oct 11, 2024

ACS Professor awards are primarily honorifics for individuals who have made seminal contributions to cancer research. Applicants must be at the rank of full professor and have made, and will likely continue to make, impactful contributions to change the direction of cancer research. Awards can be budgeted at the applicant’s discretion to support creative and innovative pursuits in cancer research.

LOI Deadline - August 1, 2024

Budget | Period - $ 400,000 | 5 years

Applications are required to address one or more of the following FY24 PCRP Overarching Challenges:

LOI Deadline - August 9, 2024

Application Deadline - August 30, 2024

Budget | Period - $ 2,000,000 | 4 years

Cancer Cell

Robert Saddawi-Konefka MD, PhD (Cancer Biology and Signaling), J. Silvio Gutkind PhD (Cancer Biology and Signaling)

Nature Medicine

Tyler Stewart MD (Solid Tumor Therapeutics)

Cancer Cell

Rana R. McKay MD (Solid Tumor Therapeutics)

Gastroenterology

Andrew M. Lowy MD, FACS (Solid Tumor Therapeutics), Scott M. Lippman MD (Cancer Control)

PI: Lyudmila Bazhenova, MD

NCT: NCT05652868

PI: Adam Burgoyne, MD

NCT: NCT05883644

PI: Shumei Kato, MD

NCT: NCT05546268

PI: Sandip Patel, MD

NCT: NCT05812027

Department of Research Administration

3855 Health Sciences Drive, La Jolla, CA 92037

moorescancercenter.ucsd.edu

Unsubscribe | Privacy Policy | Submit Feedback